Table 3 Fractional Excretion of Protein Glycation, Oxidation and Nitration Free Adducts (%).
Free adduct | Normoalbuminuria (n = 30) | Microalbuminuria (n = 55) | P value (NA vs MA) | NA and stable GFR (n = 63) | Early GFR decline (n = 22) | P value stable vs early GFR decline |
|---|---|---|---|---|---|---|
FL | 100 [54–160] | 153 [79–247] | 100 [58–204] | 204 [114–257] | < 0.05 | |
CML | 30.4 [25.0–39.4] | 43.6 [22.1–71.9] | 30.6 [21.7–43.5] | 52.3 [44.8–81.9] | < 0.01* | |
CEL | 26.4 [16.0–33.7] | 28.3 [18.1–52.9] | 25.1 [12.6–34.4] | 42.4 [26.0–52.0] | < 0.05 | |
G-H1 | 30.7 [15.0–60.0] | 14.5 [5.3–30.0] | < 0.01* | 19.6 [6.9–39.6] | 17.9 [13.4–44.1] | |
MG-H1 | 113 [91 -146] | 123 [73–263] | 111 [71–156] | 182 [115–290] | < 0.05 | |
3DG-H | 15.0 [11.6–23.5] | 15.8 [8.4–27.9] | 14.0 [8.9–22.7] | 19.8 [14.1–39.9] | ||
CMA | 4.3 [2.9–5.6] | 22.4 [7.2–57.5] | < 0.001* | 6.0 [3.9–23.6] | 32.2 [7.6–89.6] | < 0.001* |
Pentosidine | 8.8 [5.0–20.3] | 97.1 [38.2–141.1] | < 0.001* | 20.9 [7.3–94.9] | 109.1 [74.6–143.8] | < 0.001* |
ΣERFD predictors | 285 [223–387] | 537 [293–867] | < 0.05* | 337 [217–526] | 785 [499–991] | < 0.001* |
MetSO | 0.8 [0.3–1.6] | 0.6 [0.4–1.3] | 0.7 [0.3–1.5] | 0.6 [0.4–1.4] | ||
DT | 26.7 [20.9–43.8] | 27.8 [12.5–56.8] | 26.6 [15.6–50.6] | 29.4 [19.0–49.7] | ||
NFK | 8.8 [5.7–14.3] | 6.6 [2.6–10.7] | 7.7 [3.5–11.0] | 9.2 [3.7–12.1] | ||
3-NT | 10.5 [4.2–29.4] | 13.4 [5.7–26.6] | 13.3 [4.6–26.5] | 11.8 [7.7–30.5] |